Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
Eli Lilly(LLY) stock is priced at $1,183.56, giving the company a market capitalization of 1.11T. It carries a P/E multiple of 40.21 and pays a dividend yield of 0.57%.
On 2026-09-27, Eli Lilly(LLY) stock traded between a low of $1,160.84 and a high of $1,190.00. Shares are currently priced at $1,183.56, which is +2.0% above the low and -0.5% below the high.
The Eli Lilly(LLY)'s current trading volume is 1.92M, compared to an average daily volume of 2.34M.
During the past year, Eli Lilly(LLY) stock moved between $716.08 at its lowest and $1,292.65 at its peak.
During the past year, Eli Lilly(LLY) stock moved between $716.08 at its lowest and $1,292.65 at its peak.
LLY News
Nektar (NKTR) in 2023 filed a complaint in the U.S. District Court for the Northern District of California against Eli Lilly (LLY) alleging, among other claims,...
Investing Eli Lilly Just Won FDA Approval for a Once Weekly Insulin and the Stock Is Knocking on $1,200 The FDA just handed Eli Lilly a new diabetes approval, b...
has turned into one of the most closely watched pharmaceutical stocks, with the share price at US$1,183.46 and a very large 5 year gain putting fresh focus on w...
Analyst ratings
84%
of 32 ratingsMore LLY News
Key Points Eli Lilly was second to market with a GLP-1 drug, but it quickly became the industry leader. The company recognizes that patents will only protect...
Eli Lilly (LLY) and Company announced that the U.S. FDA approved Olumiant, a once-daily pill, for the treatment of pediatric patients 12 years of age and older...
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. The phase 3 ADVANCE-SURMOUNT-KIDS study, officially titled “Efficacy, Safety,...
A federal jury in California has awarded Nektar Therapeutics Inc. (NASDAQ:NKTR) $90 million in damages, finding that Eli Lilly and Co. (NYSE:LLY) breached the i...
Nektar Therapeutics ( (NKTR) ) has issued an announcement. In August 2023, Nektar Therapeutics filed a complaint in the U.S. District Court for the Northern Di...
Key Points Novo this week laid out an ambitious strategy to reignite growth beyond its top-selling Wegovy and Ozempic injections, but faces an uphill battle to...
Eli Lilly (LLY) just secured U.S. FDA approval for Onswik, a once weekly basal insulin for adults with type 2 diabetes, an update that quickly drew investor att...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.